Conformis

Conformis EBITDA per Employee

Delisted

The EBITDA per Employee of Conformis (CFMS) as of Oct 22, 2026 is -176,633.59 USD. In the previous year, EBITDA per Employee was 259.54 USD — a change of -68,155.88% (lower).

EBITDA per Employee

-176,633.59USD

YoY

-68,155.88%

Last updated:

EBITDA per Employee of Conformis is 2022 -176,633.59 USD. EBITDA per Employee of Conformis was 2021 259.54 USD. It decreases by -68,155.88% lower compared to the previous year.

The Conformis EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2015
-213,591.60 USD
Jan 1, 2016
-214,290.08 USD
Jan 1, 2017
-213,156.49 USD
Jan 1, 2018
-135,206.11 USD
Jan 1, 2019
-95,912.21 USD
Jan 1, 2020
-95,854.96 USD
Jan 1, 2021
259.54 USD
Jan 1, 2022
-176,633.59 USD
The Conformis EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-176,633.59USD-68,155.88%
259.54USD-100.27%
-95,854.96USD-0.06%
-95,912.21USD-29.06%
-135,206.11USD-36.57%
-213,156.49USD-0.53%
-214,290.08USD+0.33%
-213,591.60USD+23.19%
-173,377.86USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Conformis Stock analysis

What does Conformis do? Conformis Inc is a medical technology company that specializes in the development, manufacturing, and marketing of customized implantable joint prostheses. The company is based in the United States and has its headquarters in Billerica, Massachusetts. History: Conformis Inc was founded in 2004 by Dr. Philipp Lang, an orthopedic surgeon and pioneer in the development of customized implants. The company's goal was to develop an innovative technology that could be used to manufacture individual prostheses for patients. Initially, Conformis focused on the development of custom prostheses for the knee joint. Over the years, the company has expanded its offerings to include other joints such as the hip. Business model: Conformis' business model is based on providing customized, implantable prostheses. Unlike traditional prostheses that are available in standard sizes, Conformis prostheses are individually manufactured for each patient. The company uses advanced 3D printing technology to produce a prosthesis that matches the specific anatomical features of the patient. Conformis prostheses offer numerous advantages over conventional prostheses. By customizing the prosthesis, a better fit and higher stability can be achieved. This can lead to better function and increased lifespan of the prosthesis. Additionally, Conformis prostheses can be implanted faster and more easily than traditional prostheses. Divisions: Conformis offers a variety of products for different joints. Knee prostheses: Conformis offers a wide range of custom knee prostheses. The offerings include partial replacement prostheses that only replace a part of the knee, as well as complete knee prostheses. All prostheses are individually manufactured for each patient to ensure optimal fit and function. Hip prostheses: Conformis also offers custom prostheses for the hip. These prostheses are designed to provide high stability and better fit. The hip prostheses are also individually made for each patient. Shoulder prostheses: Conformis offers custom prostheses for the shoulder, which are also tailored to the patient's anatomy. These prostheses can be used for rotator cuff defects as well as other shoulder problems. Products: The core product of Conformis is custom joint prostheses. The company's prostheses are individually manufactured for each patient to ensure optimal fit and function. Advanced technologies such as 3D printing and digital imaging are used in the production process. Conformis also offers implants for specialized procedures such as medial knee replacement. In addition to the prostheses, Conformis also offers implants such as screws, pins, and plates that can be used to fix bones during surgery. Conclusion: Conformis is a leading company in the medical technology field and offers specialized products that cater to the needs of patients. The company specializes in customized implantable joint prostheses and offers a wide range of products that are tailored to the needs of patients. Conformis has earned an excellent reputation in the industry and continues to strive to develop innovative products that improve the lives of patients. Conformis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Conformis stock

EBITDA per Employee of Conformis is -176,633.59 USD in 2022.

EBITDA per Employee of Conformis changed from 259.54 USD to -176,633.59 USD, representing a -68,155.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Conformis since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Conformis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Conformis

All Key Metrics — Conformis